Stem cells in the treatment of disease

HM Blau, GQ Daley - New England Journal of Medicine, 2019 - Mass Medical Soc
Stem-Cell Research and Clinical Application Stem cells have been the focus of hope, hype,
and a great deal of research. But what exactly is a stem cell, and what are its uses? This …

Engineered skeletal muscles for disease modeling and drug discovery

J Wang, A Khodabukus, L Rao, K Vandusen… - Biomaterials, 2019 - Elsevier
Skeletal muscle is the largest organ of human body with several important roles in everyday
movement and metabolic homeostasis. The limited ability of small animal models of muscle …

Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000 …

S Thomas, KM Conway, O Fapo, N Street… - Muscle & …, 2022 - Wiley Online Library
Abstract Introduction/Aims With current and anticipated disease‐modifying treatments,
including gene therapy, an early diagnosis for Duchenne muscular dystrophy (DMD) is …

Restoring dystrophin expression in Duchenne muscular dystrophy: current status of therapeutic approaches

Y Shimizu-Motohashi, H Komaki, N Motohashi… - Journal of personalized …, 2019 - mdpi.com
Duchenne muscular dystrophy (DMD), a rare genetic disorder characterized by progressive
muscle weakness, is caused by the absence or a decreased amount of the muscle …

Novel therapies for prevention and early treatment of cardiomyopathies: now and in the future

GG Repetti, CN Toepfer, JG Seidman… - Circulation …, 2019 - Am Heart Assoc
Heritable cardiomyopathies are a class of heart diseases caused by variations in a number
of genetic loci. Genetic variants on one allele lead to either a degraded protein, which …

Translating musculoskeletal bioengineering into tissue regeneration therapies

A Khodabukus, T Guyer, AC Moore… - Science translational …, 2022 - science.org
Musculoskeletal injuries and disorders are the leading cause of physical disability
worldwide and a considerable socioeconomic burden. The lack of effective therapies has …

Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity

L Steinman, PP Ho, WH Robinson, PJ Utz… - Current opinion in …, 2019 - Elsevier
Highlights•Current therapies for autoimmunity halt natural immune surveillance.•High doses
of Factor VIII administered in hemophilia A induce tolerance.•Gene replacement therapy can …

Emerging proteomic biomarkers of X-linked muscular dystrophy

P Dowling, S Murphy, M Zweyer… - Expert Review of …, 2019 - Taylor & Francis
Introduction: Progressive skeletal muscle wasting is the manifesting symptom of Duchenne
muscular dystrophy, an X-linked inherited disorder triggered by primary abnormalities in the …

Dystrophin-and utrophin-based therapeutic approaches for treatment of duchenne muscular dystrophy: a comparative review

S Szwec, Z Kapłucha, JS Chamberlain, P Konieczny - BioDrugs, 2024 - Springer
Duchenne muscular dystrophy is a devastating disease that leads to progressive muscle
loss and premature death. While medical management focuses mostly on symptomatic …

Gene transfer to skeletal muscle using hydrodynamic limb vein injection: Current applications, hurdles and possible optimizations

YT Le Guen, T Le Gall, P Midoux… - The journal of gene …, 2020 - Wiley Online Library
Hydrodynamic limb vein injection is an in vivo locoregional gene delivery method. It consists
of administrating a large volume of solution containing nucleic acid constructs in a limb with …